Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Eargo, Inc. (EAR : NSDQ)
 
 • Company Description   
Eargo Inc. is a medical device company. Its product and go-to-market approach address challenges of traditional hearing aid adoption. Eargo Inc. is based in SAN JOSE, Calif.

Number of Employees: 238

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.49 Daily Weekly Monthly
20 Day Moving Average: 1,163,860 shares
Shares Outstanding: 39.35 (millions)
Market Capitalization: $58.64 (millions)
Beta: 3.55
52 Week High: $40.21
52 Week Low: $1.17
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -61.20% -57.65%
12 Week -68.89% -67.25%
Year To Date -70.78% -65.94%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2665 North First Street Suite 300
-
San Jose,CA 95134
USA
ph: 650-351-7700
fax: -
ir@eargo.com http://eargo.com
 
 • General Corporate Information   
Officers
Christian Gormsen - President; Chief Executive Officer and Director
Josh Makower, M.D - Chair of the Board
Adam Laponis - Chief Financial Officer
Mark Thorpe - Chief Accounting Officer
Katie J. Bayne - Director

Peer Information
Eargo, Inc. (ABMD)
Eargo, Inc. (DMDS)
Eargo, Inc. (CPWY.)
Eargo, Inc. (EQUR)
Eargo, Inc. (ECIA)
Eargo, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 270087109
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/21
Next Expected EPS Date: 05/18/22
Share - Related Items
Shares Outstanding: 39.35
Most Recent Split Date: (:1)
Beta: 3.55
Market Capitalization: $58.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/18/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 0.50
PEG Ratio: -
Price Ratios
Price/Book: 0.85
Price/Cash Flow: -
Price / Sales: 0.69
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -127.27%
Sales Growth
vs. Year Ago Period: 43.73%
vs. Previous Quarter: 3.79%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©